GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Psyence Group Inc (OTCPK:PSYGD) » Definitions » Gross-Profit-to-Asset %

PSYGD (Psyence Group) Gross-Profit-to-Asset % : 0.00% (As of Dec. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Psyence Group Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Psyence Group's annualized Gross Profit for the quarter that ended in Dec. 2024 was $0.00 Mil. Psyence Group's average Total Assets over the quarter that ended in Dec. 2024 was $5.73 Mil. Therefore, Psyence Group's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 was 0.00%.


Psyence Group Gross-Profit-to-Asset % Historical Data

The historical data trend for Psyence Group's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Group Gross-Profit-to-Asset % Chart

Psyence Group Annual Data
Trend Dec19 Dec20 Mar22 Mar23 Mar24
Gross-Profit-to-Asset %
- - - - -

Psyence Group Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Psyence Group's Gross-Profit-to-Asset %

For the Drug Manufacturers - General subindustry, Psyence Group's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Psyence Group's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Psyence Group's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Psyence Group's Gross-Profit-to-Asset % falls into.


;
;

Psyence Group Gross-Profit-to-Asset % Calculation

Psyence Group's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Mar. 2024 )/( (Total Assets (A: Mar. 2023 )+Total Assets (A: Mar. 2024 ))/ count )
=0/( (2.924+2.417)/ 2 )
=0/2.6705
=0.00 %

Psyence Group's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2024 )/( (Total Assets (Q: Sep. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=0/( (3.081+8.384)/ 2 )
=0/5.7325
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Psyence Group Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Psyence Group's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Psyence Group Business Description

Traded in Other Exchanges
Address
121 Richmond Street West, Penthouse Suite, 1300, Toronto, ON, CAN, M5H 2K1
Psyence Group Inc is a life science biotechnology company focused on the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma in the context of palliative care and in support of mental wellness.

Psyence Group Headlines

No Headlines